Open AccessShould We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea
Author(s) -
Do Yeun Kim,
Hyerim Ha,
Seung Jin Bae,
Jin Hyoung Kang
Publication year - 2021
Publication title -
journal of korean medical science/journal of korean medical science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.743
H-Index - 66
eISSN - 1598-6357
pISSN - 1011-8934
DOI - 10.3346/jkms.2021.36.e191
Subject(s) - medicine , reimbursement , cancer , clinical oncology , oncology , personalized medicine , cancer drugs , drug development , precision medicine , family medicine , intensive care medicine , health care , drug , pharmacology , bioinformatics , pathology , economics , biology , economic growth